Neurosurgery, Padua Hospital, Via Giustiniani 1, 35100 Padova, Italy.
Acta Neurochir (Wien). 2010 Feb;152(2):287-92. doi: 10.1007/s00701-009-0512-1. Epub 2009 Sep 29.
In the context of von Hippel-Lindau disease (VHL), the medulla oblongata is a relatively frequent site of growth of hemangioblastomas, posing related clinical and surgical difficulties. Their management requires a close correlation between clinical evolution and morphological surveillance. In order to describe their clinical and surgical features, we reviewed our experience in the treatment of these lesions.
Between 2001 and 2009, 14 patients (9 female and 5 male, mean age 34 years) underwent removal of 15 lower brain stem hemangioblastomas. Based on the review of the clinical records and outpatient long-term follow-up visits, their clinical course was analyzed. Functional evaluation was measured with the Karnofsky Performance Scale (KPS) on admission, at discharge and at the last follow-up. The mean follow-up period was 30.8 months (range 4-99).
All the operated hemangioblastomas were located in the dorsal medulla oblongata, in the context of multiple lesions, cerebellar and/or spinal. In ten patients hemangioblastomas were located in a median position at the obex area; in four cases a lateral location was observed. Cystic component was absent in two cases. Clinical onset preceded surgery by a mean of 8.5 months. Preoperatively three patients showed a KPS lower than 80, ten patients between 80 and 90, and one patient scored 100 (asymptomatic). There was no surgical mortality. Nine out of 14 patients showed a temporary surgical morbidity. One patient required a tracheostomy. At follow-up ten patients scored a KPS better than before the operation, while the other four patients remained stable. Permanent morbidity was observed in three patients.
Lower brain stem hemangioblastomas in the context of VHL show an often gradual onset of signs and symptoms except for patients who develop an obstructive hydrocephalus. Although transient surgical complications are possible, surgery provides favorable long-term results.
在 von Hippel-Lindau 病(VHL)中,延髓是成血管细胞瘤生长的相对常见部位,这给临床和外科带来了相关的困难。它们的管理需要临床演变与形态监测密切相关。为了描述它们的临床和外科特征,我们回顾了我们治疗这些病变的经验。
在 2001 年至 2009 年间,14 名患者(9 名女性和 5 名男性,平均年龄 34 岁)接受了 15 例下脑干部位血管母细胞瘤切除术。基于对临床记录和门诊长期随访的回顾,分析了他们的临床过程。功能评估通过入院时、出院时和最后一次随访时的 Karnofsky 表现量表(KPS)进行测量。平均随访时间为 30.8 个月(范围 4-99)。
所有手术切除的血管母细胞瘤均位于延髓背侧,与小脑和/或脊髓中的多发病变相关。在 10 名患者中,血管母细胞瘤位于延髓尖区的正中位置;4 例为侧位。2 例无囊性成分。临床发病时间平均比手术提前 8.5 个月。术前有 3 名患者的 KPS 评分低于 80,10 名患者的 KPS 评分在 80-90 之间,1 名患者的 KPS 评分 100(无症状)。无手术死亡。14 名患者中有 9 名出现暂时性手术并发症。1 名患者需要气管切开术。随访时,10 名患者的 KPS 评分较术前提高,而其他 4 名患者保持稳定。3 名患者出现永久性并发症。
VHL 背景下的下脑干部位血管母细胞瘤除了发生梗阻性脑积水的患者外,通常表现为逐渐出现的症状和体征。尽管可能出现短暂的手术并发症,但手术能提供良好的长期效果。